|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6309883B1
(en)
|
1994-02-17 |
2001-10-30 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US20060257890A1
(en)
|
1996-05-20 |
2006-11-16 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US6395547B1
(en)
|
1994-02-17 |
2002-05-28 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6995017B1
(en)
|
1994-02-17 |
2006-02-07 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
CA2191718A1
(en)
|
1994-06-03 |
1995-12-14 |
Randy M. Berka |
Phosphonyldipeptides useful in the treatment of cardiovascular diseases
|
|
ATE294871T1
(de)
|
1994-06-30 |
2005-05-15 |
Novozymes Biotech Inc |
Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
|
|
US5483345A
(en)
|
1994-09-06 |
1996-01-09 |
Mrs Technology, Inc. |
Alignment system for use in lithography utilizing a spherical reflector having a centered etched-on projection object
|
|
FI104465B
(fi)
|
1995-06-14 |
2000-02-15 |
Valio Oy |
Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
|
|
CA2236381A1
(en)
*
|
1995-11-01 |
1997-05-09 |
Bg Plc |
Mutant mono-oxygenase cytochrome p450cam
|
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
|
EP1717322B1
(en)
|
1997-01-17 |
2012-07-18 |
Codexis Mayflower Holdings, LLC |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
US7148054B2
(en)
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
IL136574A0
(en)
|
1997-12-08 |
2001-06-14 |
California Inst Of Techn |
A method for forming a polynucleotide of desired properties
|
|
US6365408B1
(en)
|
1998-06-19 |
2002-04-02 |
Maxygen, Inc. |
Methods of evolving a polynucleotides by mutagenesis and recombination
|
|
JP4221100B2
(ja)
|
1999-01-13 |
2009-02-12 |
エルピーダメモリ株式会社 |
半導体装置
|
|
US6436675B1
(en)
|
1999-09-28 |
2002-08-20 |
Maxygen, Inc. |
Use of codon-varied oligonucleotide synthesis for synthetic shuffling
|
|
US6368861B1
(en)
|
1999-01-19 |
2002-04-09 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US6376246B1
(en)
|
1999-02-05 |
2002-04-23 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US6917882B2
(en)
|
1999-01-19 |
2005-07-12 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US6961664B2
(en)
|
1999-01-19 |
2005-11-01 |
Maxygen |
Methods of populating data structures for use in evolutionary simulations
|
|
US7702464B1
(en)
|
2001-08-21 |
2010-04-20 |
Maxygen, Inc. |
Method and apparatus for codon determining
|
|
US7024312B1
(en)
|
1999-01-19 |
2006-04-04 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
JP2002534965A
(ja)
|
1999-01-19 |
2002-10-22 |
マキシジェン， インコーポレイテッド |
所望の特徴を有する文字ストリング、ポリヌクレオチドおよびポリペプチドを作製するための方法
|
|
AU3391900A
(en)
|
1999-03-05 |
2000-09-21 |
Maxygen, Inc. |
Encryption of traits using split gene sequences
|
|
US7430477B2
(en)
|
1999-10-12 |
2008-09-30 |
Maxygen, Inc. |
Methods of populating data structures for use in evolutionary simulations
|
|
US6519065B1
(en)
|
1999-11-05 |
2003-02-11 |
Jds Fitel Inc. |
Chromatic dispersion compensation device
|
|
AU4964101A
(en)
|
2000-03-30 |
2001-10-15 |
Maxygen Inc |
In silico cross-over site selection
|
|
US7747391B2
(en)
|
2002-03-01 |
2010-06-29 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
EP2315145B1
(en)
|
2002-03-01 |
2015-11-25 |
Codexis Mayflower Holdings, LLC |
Methods, systems, and software for identifying functional biomolecules
|
|
US20050084907A1
(en)
|
2002-03-01 |
2005-04-21 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
WO2003078583A2
(en)
|
2002-03-09 |
2003-09-25 |
Maxygen, Inc. |
Optimization of crossover points for directed evolution
|
|
WO2005017105A2
(en)
*
|
2003-06-17 |
2005-02-24 |
California University Of Technology |
Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
|
|
GB0403992D0
(en)
*
|
2004-02-23 |
2004-03-31 |
Isis Innovation |
Oxidation by hydrogen peroxide
|
|
CN1273585C
(zh)
*
|
2004-11-29 |
2006-09-06 |
浙江大学 |
细胞色素 p450bm－3 单加氧酶变体基因及其用途
|
|
US8067433B2
(en)
*
|
2005-11-09 |
2011-11-29 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
|
MX2009003082A
(es)
*
|
2006-09-22 |
2009-04-01 |
Novartis Ag |
Metodo para optimizar el tratamiento de leucemia positiva para filadelfia, con inhibidores de cinasa de tirosina abl.
|
|
ES2488922T3
(es)
*
|
2006-09-29 |
2014-09-01 |
Idenix Pharmaceuticals, Inc. |
Fosfoindoles enantiómeramente puros como inhibidores del HIV
|
|
WO2008073498A2
(en)
|
2006-12-12 |
2008-06-19 |
The Regents Of The University Of California |
Artemisinic epoxide and methods for producing same
|
|
US20080268517A1
(en)
*
|
2007-02-08 |
2008-10-30 |
The California Institute Of Technology |
Stable, functional chimeric cytochrome p450 holoenzymes
|
|
US8802401B2
(en)
*
|
2007-06-18 |
2014-08-12 |
The California Institute Of Technology |
Methods and compositions for preparation of selectively protected carbohydrates
|
|
GB0719620D0
(en)
*
|
2007-10-08 |
2007-11-14 |
Isis Innovation |
Mutant Enzymes
|
|
ES2705694T3
(es)
|
2008-06-13 |
2019-03-26 |
Codexis Inc |
Método de síntesis de variantes de polinucleótidos
|
|
US20090312196A1
(en)
|
2008-06-13 |
2009-12-17 |
Codexis, Inc. |
Method of synthesizing polynucleotide variants
|
|
US8383346B2
(en)
|
2008-06-13 |
2013-02-26 |
Codexis, Inc. |
Combined automated parallel synthesis of polynucleotide variants
|
|
EP2426198A1
(en)
*
|
2010-09-03 |
2012-03-07 |
B.R.A.I.N. Biotechnology Research And Information Network AG |
Cytochrome P450 monooxygenase variants
|
|
US9273342B2
(en)
*
|
2011-02-11 |
2016-03-01 |
University Of Rochester |
Methods and systems for evaluating and predicting the reactivity of monooxygenase enzymes
|
|
WO2013076258A2
(en)
*
|
2011-11-23 |
2013-05-30 |
Dsm Ip Assets B.V. |
P450 bm3 mutants and their use for regio- and stereoselective hydroxylation of alpha-and beta-ionone
|
|
CN102757944A
(zh)
*
|
2012-07-24 |
2012-10-31 |
浙江大学宁波理工学院 |
细胞色素p450bm-3(d168l/e435t)变体酶及其编码基因和用途
|
|
JP2015534464A
(ja)
*
|
2012-10-09 |
2015-12-03 |
カリフォルニア インスティチュート オブ テクノロジー |
ヘム酵素によって触媒されるインビボおよびインビトロオレフィンシクロプロパン化
|
|
US9708587B2
(en)
|
2014-07-09 |
2017-07-18 |
Codexis, Inc. |
P450-BM3 variants with improved activity
|
|
JP6691558B2
(ja)
*
|
2015-07-07 |
2020-04-28 |
コデクシス， インコーポレイテッド |
改善された活性を持つ新規のｐ４５０−ｂｍ３バリアント
|